These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9871868)

  • 1. New conceptual approaches for pharmacological neuroprotection in glaucomatous neuronal degeneration.
    Neufeld AH
    J Glaucoma; 1998 Dec; 7(6):434-8. PubMed ID: 9871868
    [No Abstract]   [Full Text] [Related]  

  • 2. Alpha2-adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration.
    Yoles E; Wheeler LA; Schwartz M
    Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):65-73. PubMed ID: 9888428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Characteristic features of optic nerve ganglion cells and approaches for neuroprotection. From intracellular to capillary processes and therapeutic considerations].
    Funk RH; Schmidt KG
    Ophthalmologe; 2004 Nov; 101(11):1062-70. PubMed ID: 15455253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neuroprotection in glaucoma].
    Stefan C; Melinte-Dumitrica D; Selaru D; Musat O; Zemba M; Serghiescu I
    Oftalmologia; 2010; 54(2):7-10. PubMed ID: 20827905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotection in glaucoma - Is there a future role?
    Baltmr A; Duggan J; Nizari S; Salt TE; Cordeiro MF
    Exp Eye Res; 2010 Nov; 91(5):554-66. PubMed ID: 20800593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neurodegeneration and neuroprotection].
    Schmidt KG
    Ophthalmologe; 2004 Nov; 101(11):1059-61. PubMed ID: 15449095
    [No Abstract]   [Full Text] [Related]  

  • 7. Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice.
    Zhong L; Bradley J; Schubert W; Ahmed E; Adamis AP; Shima DT; Robinson GS; Ng YS
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1212-8. PubMed ID: 17325165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some current ideas on the pathogenesis and the role of neuroprotection in glaucomatous optic neuropathy.
    Osborne NN; Chidlow G; Wood J; Casson R
    Eur J Ophthalmol; 2003 Apr; 13 Suppl 3():S19-26. PubMed ID: 12749673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotection by sodium channel blockade with phenytoin in an experimental model of glaucoma.
    Hains BC; Waxman SG
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4164-9. PubMed ID: 16249495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effect of intravitreal cell-based glucagon-like peptide-1 production in the optic nerve crush model.
    Zhang R; Zhang H; Xu L; Ma K; Wallrapp C; Jonas JB
    Acta Ophthalmol; 2011 Jun; 89(4):e320-6. PubMed ID: 21470377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanisms of neuroprotection against glaucoma].
    Mittag T; Schmidt KG
    Ophthalmologe; 2004 Nov; 101(11):1076-86. PubMed ID: 15490184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neuroprotection against glaucoma remains a concept].
    Osborne NN; Schmidt KG
    Ophthalmologe; 2004 Nov; 101(11):1087-92. PubMed ID: 15490185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotection and regeneration in glaucoma.
    Levin LA
    Ophthalmol Clin North Am; 2005 Dec; 18(4):585-96, vii. PubMed ID: 16314221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saving the nerve from glaucoma: memantine to caspaces.
    Naskar R; Vorwerk CK; Dreyer EB
    Semin Ophthalmol; 1999 Sep; 14(3):152-8. PubMed ID: 10790579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glaucoma neuroprotection: What is it? Why is it needed?
    Weinreb RN
    Can J Ophthalmol; 2007 Jun; 42(3):396-8. PubMed ID: 17508033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective effect of nipradilol [3,4-dihydro-8-(2-hydroxy-3-isopropylamino)-propoxy-3-nitroxy-2H-1-benzopyran] in a rat model of optic nerve degeneration.
    Karim MZ; Sawada A; Mizuno K; Kawakami H; Ishida K; Yamamoto T
    J Glaucoma; 2009 Jan; 18(1):26-31. PubMed ID: 19142131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of retinal transneuronal degeneration in human glaucoma: a novel multiphoton-DAPI approach.
    Lei Y; Garrahan N; Hermann B; Becker DL; Hernandez MR; Boulton ME; Morgan JE
    Invest Ophthalmol Vis Sci; 2008 May; 49(5):1940-5. PubMed ID: 18436826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ischemia and hypoxia. An attempt to explain the different rates of retinal ganglion cell death in glaucoma].
    Schmidt KG; Pillunat LE; Osborne NN
    Ophthalmologe; 2004 Nov; 101(11):1071-5. PubMed ID: 15490183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevance of the site of injury of glaucoma to neuroprotective strategies.
    Levin LA
    Surv Ophthalmol; 2001 May; 45 Suppl 3():S243-9; discussion S273-6. PubMed ID: 11377443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glaucoma as a neuropathy amenable to neuroprotection and immune manipulation.
    Schwartz M; London A
    Prog Brain Res; 2008; 173():375-84. PubMed ID: 18929122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.